BioNTech, CEPI partner to boost mRNA-based mpox vaccine development
CEPI will contribute up to $90m funding for the partnership, which will support the development of mRNA-based vaccine…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Sep 23
CEPI will contribute up to $90m funding for the partnership, which will support the development of mRNA-based vaccine…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
19 Sep 23
The US-based firm will use the investment to fund its future growth in the production of manufactures safe,…
19 Sep 23
The approval was based on the findings from the MOMENTUM study and a subpopulation of anaemia patients from…
19 Sep 23
Cabotegravir is approved for use in combination with safer sex practices as a pre-exposure prophylaxis (PrEP) method and…
19 Sep 23
CRYOcheck Factor VIII Deficient Plasma with VWF is intended for use in clinical laboratories to identify factor VIII…
19 Sep 23
Under the terms of the new agreement, Samsung Biologics will provide drug substance manufacturing for an antibody cancer…
19 Sep 23
High calibre speakers at the MEDICA MEDICINE + SPORTS CONFERENCE illuminate new methods and their practical uses
15 Sep 23
The agreement provides Sun Pharma with rights to commercialise Tyvalzi (Sovateltide) for the treatment of acute cerebral ischemic…
15 Sep 23
The investment is expected to expand Astellas’ capacity and capabilities for aseptic drug products in Ireland, strengthen stable…
15 Sep 23
US-based Generate:Biomedicines will use the funds to advance its portfolio of 17 existing programmes across oncology, immunology, and…